SenesTech, Inc. (SNES)

4.23% (1D)

Market Cap	3.41M
Revenue (ttm)	1.86M
Net Income (ttm)	-6.18M
Shares Out	1.75M
EPS (ttm)	-8.86
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	43,020
Open	1.990
Previous Close	1.890
Day's Range	1.900 - 2.100
52-Week Range	1.300 - 9.800
Beta	-0.03
Analysts	Strong Buy
Price Target	10.00 (+407.61%)
Earnings Date	May 8, 2025

About SNES

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption, as well as Evolve Mouse, a modified version of its bait technology containing the active ingredient ...

• Industry: Specialty Chemicals
• Sector: Materials
• IPO Date: Dec 8, 2016
• Employees: 23
• Stock Exchange: NASDAQ
• Ticker Symbol: SNES
• Website: https://www.senestech.com

Financial Performance

In 2024, SenesTech's revenue was $1.86 million, an increase of 55.66% compared to the previous year's $1.19 million. Losses were -$6.18 million, -19.79% less than in 2023.

Analyst Forecast

According to one analyst, the rating for SNES stock is "Strong Buy" and the 12-month stock price forecast is $10.0.

Price Target

$10.0

(407.61% upside)

Analyst Consensus: Strong Buy